ADGM stock surges as investors react to next-generation ULTA milestone

Adagio Medical Holdings, Inc. (ADGM) is up 76.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely catalyst is investor excitement around a new clinical milestone for Adagio’s next-generation ULTA ventricular ablation platform, specifically the first patient treated with its faster single-freeze system under Expanded Access. The move may also reflect renewed optimism around the company’s broader regulatory path after it recently advanced both its next-generation study program and its submission work for the current vCLAS system.

Details:

Adagio’s next-generation vCLAS Ultra catheter was previously cleared by the FDA for an IDE study expansion, allowing the company to evaluate a faster, smaller, more flexible system for ventricular tachycardia procedures.

The company has described the newer ULTA platform as capable of single-freeze applications and shorter ablation times, which can make the technology more attractive if clinical performance holds up in practice.

Adagio also submitted a PMA application in May 2026 for its first-generation vCLAS Ventricular Ablation System, giving investors a nearer-term regulatory milestone to watch.

This could also be because ADGM is a thinly traded micro-cap stock, so positive clinical headlines can trigger outsized momentum moves, especially after the company disclosed a Nasdaq minimum bid price deficiency notice in June 2026.

Sources:

SEC, Business Wire, Cardiac Rhythm News

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$ADGM Hedge Fund Activity

We have seen 8 institutional investors add shares of $ADGM stock to their portfolio, and 6 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

ARMISTICE CAPITAL, LLC removed 478,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $549,700
HUDSON BAY CAPITAL MANAGEMENT LP removed 296,369 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $340,824
SILVERARC CAPITAL MANAGEMENT, LLC removed 263,412 shares (-51.1%) from their portfolio in Q1 2026, for an estimated $302,923
ADAGE CAPITAL PARTNERS GP, L.L.C. added 200,000 shares (+18.9%) to their portfolio in Q1 2026, for an estimated $229,999
OPALEYE MANAGEMENT INC. removed 92,127 shares (-83.3%) from their portfolio in Q1 2026, for an estimated $105,946
GEODE CAPITAL MANAGEMENT, LLC added 56,899 shares (+83.3%) to their portfolio in Q1 2026, for an estimated $65,433
ADAR1 CAPITAL MANAGEMENT, LLC added 45,833 shares (+4.0%) to their portfolio in Q1 2026, for an estimated $52,707

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$ADGM Price Targets

Multiple analysts have issued price targets for $ADGM recently. We have seen 2 analysts offer price targets for $ADGM in the last 6 months, with a median target of $3.0.

Here are some recent targets:

Alex Nowark from LUCID CAPITAL MARKETS set a target price of $3.0 on 06/03/2026
Matt O'Brien from Piper Sandler set a target price of $3.0 on 04/14/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.